⌘K
Loading ticker…
As of 2026-08-24, CME Group Inc. (CME) has a 3-month relative strength percentile of 39 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 48. The current market Stance is 47.8 (Neutral). Sector: Financials, ranked 4 of 11. Average daily range 2.2%, relative volume 0.67×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
CME is in a stage 1 base, week 5. Currently in a 121-day base; basing ADR 2.4% (broad 2.0%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 10.6% / 0.2%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
CME is held by 80 ETFs as of May 2026. Top owner: VFH at 1.19% weight, $160M notional. Top 3 carry $345M.
Held by 322 ETFs · $16.4B across latest filings · largest weight 4.40% (IAI).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VFHVanguard Financials ETF | 1.19% | $160M | −0.20 pp |
| SCHXSchwab U.S. Large-Cap ETF | 0.14% | $104M | −0.04 pp |
| SPMOInvesco S&P 500 Momentum ETF | 0.41% | $81M | −0.75 pp |
| SPLVInvesco S&P 500 Low Volatility ETF | 0.94% | $65M | −0.17 pp |
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.29% |
| $63M |
| −0.07 pp |
| MGV | 0.47% | $60M | −0.10 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.14% | $58M | −0.04 pp |
| SCHVSchwab U.S. Large-Cap Value ETF | 0.32% | $50M | −0.07 pp |
| VOOG | 0.15% | $41M | −0.06 pp |
| CGDG | 0.80% | $41M | −0.13 pp |
Showing 10 of 80 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CME Jan avg: 2.62% median: 3.45% win: 75% σ: 3.69% n: 4 2022-04-12 → 2026-07-31 | CME Feb avg: 7.45% median: 7.17% win: 100% σ: 2.31% n: 4 2022-04-12 → 2026-07-31 | CME Mar avg: -0.50% median: 0.51% win: 50% σ: 5.57% n: 4 2022-04-12 → 2026-07-31 | CME Apr avg: -2.46% median: -2.62% win: 20% σ: 4.61% n: 5 2022-04-12 → 2026-07-31 | CME May avg: -3.39% median: -3.78% win: 20% σ: 4.93% n: 5 2022-04-12 → 2026-07-31 | CME Jun avg: -4.09% median: -3.14% win: 40% σ: 9.24% n: 5 2022-04-12 → 2026-07-31 | CME Jul avg: 5.12% median: 0.97% win: 60% σ: 9.81% n: 5 2022-04-12 → 2026-07-31 | CME Aug avg: 1.77% median: -0.03% win: 50% σ: 6.88% n: 4 2022-04-12 → 2026-07-31 (current) | CME Sep avg: -1.75% median: 0.08% win: 50% σ: 5.34% n: 4 2022-04-12 → 2026-07-31 | CME Oct avg: 1.21% median: 0.20% win: 50% σ: 4.09% n: 4 2022-04-12 → 2026-07-31 | CME Nov avg: 3.94% median: 3.95% win: 100% σ: 2.17% n: 4 2022-04-12 → 2026-07-31 | CME Dec avg: -3.42% median: -3.27% win: 0% σ: 0.98% n: 4 2022-04-12 → 2026-07-31 |